Update in diffuse parenchymal lung disease 2010. - Wikidata - awgldk - TriplyDB

Update in diffuse parenchymal lung disease 2010.

Update in diffuse parenchymal lung disease 2010.

http://www.wikidata.org/entity/Q37877430

about

Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease.

P2860

Q37707613-716CC533-F458-4D61-9333-E6B48DF3816A

P2860

Update in diffuse parenchymal lung disease 2010.

http://www.wikidata.org/entity/Q37877430

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Update in diffuse parenchymal lung disease 2010.

@en

Update in diffuse parenchymal lung disease 2010.

@nl

type

label

Update in diffuse parenchymal lung disease 2010.

@en

Update in diffuse parenchymal lung disease 2010.

@nl

prefLabel

Update in diffuse parenchymal lung disease 2010.

@en

Update in diffuse parenchymal lung disease 2010.

@nl

P1433

Q37877430-F4E42E7F-E353-4E7D-A913-00BCB506C11B

P1476

Q37877430-20C502CE-AA48-45AB-905F-C8F6F25879A4

P2093

Q37877430-075490E6-84A5-4E00-B6FC-6AB01AB79EF1

Q37877430-3886954B-AE98-4329-84BA-FFD7EDED5910

Q37877430-CFC48C42-BBD3-4844-8BDD-2370B7B2F494

P2860

Q37877430-01132DEE-ACAE-4B88-98D4-C80479979265

Q37877430-0225B7F5-5F3A-427B-95E8-8249A9DA1BFE

Q37877430-04C8FF23-92C0-42EC-8CC2-F053F7B97808

Q37877430-0599D437-8EC2-40AB-A58D-E7D36C3C8B4F

Q37877430-1017E348-D96F-48E5-A5D0-3D489BBE8366

Q37877430-1197F048-2F82-4090-A1BF-406AC3AD3DBA

Q37877430-1C6F4D4F-B2AA-4ADE-8A1F-FACFBB1A4437

Q37877430-1FEAB6E0-D541-41FD-93C3-E3CCCD55D482

Q37877430-238D19E3-A426-4288-872E-1A5BA611A02E

Q37877430-2990099B-BBD5-40AE-A293-23B9E1E0CA48

P304

Q37877430-960CA43B-9642-4845-BE20-7093CE98DA7F

P31

Q37877430-F809BBC8-5C23-4D80-8F8E-3C4E5CF229AF

P356

Q37877430-136A58FB-242A-42B7-9698-30950B767D36

P407

Q37877430-D5EB072B-38B2-405F-AC16-D6C643B385AC

P433

Q37877430-13FD79AF-F70B-44C5-B789-67AD2B113382

P478

Q37877430-08E3BB0E-8C20-434E-9DA7-6601B9CE13CD

P577

Q37877430-E17052F8-AFF5-4075-892B-D873711E5DD3

P698

Q37877430-B2F0DC67-121D-4CD7-931F-203038CE437F

P356

RCCM.201102-0298UP

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Update in diffuse parenchymal lung disease 2010.

@en

P2093

Andreas Guenther

http://www.w3.org/2001/XMLSchema#string

Malgorzata Wygrecka

http://www.w3.org/2001/XMLSchema#string

Philipp Markart

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition and role of let-7d in idiopathic pulmonary fibrosis

CARD15/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis

Pirfenidone in idiopathic pulmonary fibrosis

Safety and tolerability of inhaled heparin in idiopathic pulmonary fibrosis.

Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2.

Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)

Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis.

Fibroblast growth factor receptors control epithelial-mesenchymal interactions necessary for alveolar elastogenesis.

Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis

Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis

P304

1316-1321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201102-0298UP

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

183

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21596834

http://www.w3.org/2001/XMLSchema#string